Sukhani upbeat on Cipla, Dr Reddys Labs

Sudarshan Sukhani, s2analytics.com is upbeat on Cipla and Dr Reddys Labs.
 
Sukhani told CNBC-TV18, “I have been very upbeat on Cipla and Dr Reddys Laboratories in different forms. Every correction in them is a buying opportunity. Fortunately Dr Reddys Laboratories is breaking into new highs and it is a buy here even at current levels.”
 
He further added, “Pharmaceutical probably is a buying opportunity for stocks that are showing strength. Both the stocks you named as well as Sun Pharmaceutical Industries come in that category.”